These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30554586)

  • 1. [Establishment and application of quantitative detection of serum anti-carbamylated protein autoantibodies by microarray chemiluminescence immunoassay].
    Yao X; Xue M; Gui T; Ma C; Jiang X; Yan H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):924-930. PubMed ID: 30554586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis].
    Li Z; Luo C; Wu L; Wu X; Meng X; Chen X; Shi Y; Zhong Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug; 56(4):729-734. PubMed ID: 39041572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of anti-carbamylated protein antibodies in patients with rheumatoid arthritis-associated intersitial lung disease].
    Zhu H; Zhao LJ; Zhou Y; Chen Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1003-1007. PubMed ID: 31848494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
    Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
    Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid Factor, Anti-Cyclic Citrullinated Peptide Antibody, C-Reactive Protein, and Erythrocyte Sedimentation Rate for the Clinical Diagnosis of Rheumatoid Arthritis.
    Shen R; Ren X; Jing R; Shen X; Chen J; Ju S; Yang C
    Lab Med; 2015; 46(3):226-9. PubMed ID: 26199263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of anti-carbamylated protein antibody in patients with rheumatoid arthritis: association with disease activity and bone destruction.
    Zhang B; Lei Y; Li X; Gao Z; Xia L; Lu J; Shen H
    J Investig Med; 2020 Aug; 68(6):1186-1192. PubMed ID: 32690598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
    Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
    Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of anti-Sa antibody and anti-carbamylated protein antibody for rheumatoid arthritis].
    Lyu YK; Li ZA; A XR; Ma JD; Zhou JW; Wang LJ
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2947-2951. PubMed ID: 37752054
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients.
    Elsayed SA; Esmail MA; Ali RM; Mohafez OM
    Clin Rheumatol; 2019 Oct; 38(10):2683-2689. PubMed ID: 31161487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    Nakabo S; Yoshifuji H; Hashimoto M; Imura Y; Nakashima R; Murakami K; Kuramoto N; Ito S; Satoh J; Tanaka M; Fujii T; Mimori T; Ohmura K
    J Rheumatol; 2017 Sep; 44(9):1384-1388. PubMed ID: 28507178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis.
    Dibrov DA; Avdeeva AS; Diatroptov ME; Nasonov EL
    Dokl Biochem Biophys; 2024 Aug; 517(1):235-242. PubMed ID: 39002007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
    Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM
    J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
    van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
    Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Anti-Carbamylated Protein Antibody Testing in the Routine Evaluation of Rheumatoid Arthritis from a Single Center.
    Nelson HA; Novis CL; Lebiedz-Odrobina D; Nandakumar V
    J Appl Lab Med; 2024 Mar; 9(2):251-261. PubMed ID: 38029448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
    Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
    J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
    Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
    Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.
    Nakabo S; Hashimoto M; Ito S; Furu M; Ito H; Fujii T; Yoshifuji H; Imura Y; Nakashima R; Murakami K; Kuramoto N; Tanaka M; Satoh J; Ishigami A; Morita S; Mimori T; Ohmura K
    Rheumatology (Oxford); 2017 Jul; 56(7):1217-1226. PubMed ID: 28398552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.